Xin-xin F. Cao

Beijing, 100021, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications

Clinical spectrum of pediatric-onset Erdheim-Chester disease: insights from a single-center case series.

Clinical spectrum of pediatric-onset Erdheim-Chester disease: insights from a single-center case series.

Journal: Frontiers in pediatrics
Published: March 09, 2026

Case Report: Erdheim-Chester disease with liver involvement successfully treated with trametinib.

Case Report: Erdheim-Chester disease with liver involvement successfully treated with trametinib.

Journal: Frontiers in oncology
Published: November 05, 2025

A case of osteopetrosis type Ⅱ presenting with anemia, splenomegaly, and thrombocytopenia

A case of osteopetrosis type Ⅱ presenting with anemia, splenomegaly, and thrombocytopenia

Journal: Zhonghua nei ke za zhi
Published: October 13, 2025

Research on the pattern and influencing factors of cardiometabolic multimorbidity in China

Research on the pattern and influencing factors of cardiometabolic multimorbidity in China

Journal: Zhonghua xin xue guan bing za zhi
Published: July 24, 2025

Luvometinib in patients with Langerhans cell histiocytosis, Erdheim-Chester disease, and other histiocytic neoplasms: a single-arm, multicentre, phase 2 study.

Luvometinib in patients with Langerhans cell histiocytosis, Erdheim-Chester disease, and other histiocytic neoplasms: a single-arm, multicentre, phase 2 study.

Journal: EClinicalMedicine
Published: June 26, 2025

Evidence of the modified staging system and comparative performance of IPSS and revised IPSS in a Single-Center Asian cohort with Waldenström macroglobulinemia.

Evidence of the modified staging system and comparative performance of IPSS and revised IPSS in a Single-Center Asian cohort with Waldenström macroglobulinemia.

Journal: Leukemia & lymphoma
Published: May 18, 2025

Langerhans Cell Histiocytosis With MAP2K1E102_I103del Mutation Successfully Treated With Trametinib.

Langerhans Cell Histiocytosis With MAP2K1E102_I103del Mutation Successfully Treated With Trametinib.

Journal: EJHaem
Published: March 22, 2025

Diagnosis and treatment of Langerhans cell histiocytosis in adults.

Diagnosis and treatment of Langerhans cell histiocytosis in adults.

Journal: Innovation (Cambridge (Mass.))
Published: March 20, 2025

Extensive sclerotic skin involvement in Erdheim-Chester disease.

Extensive sclerotic skin involvement in Erdheim-Chester disease.

Journal: QJM : monthly journal of the Association of Physicians
Published: December 17, 2024

Long-term follow-up of methotrexate and cytarabine in adult patients with Langerhans cell histiocytosis.

Long-term follow-up of methotrexate and cytarabine in adult patients with Langerhans cell histiocytosis.

Journal: British journal of haematology
Published: July 29, 2024

Clinical Spectrum and Outcome of Kidney Involvement in Non-Langerhans Histiocytosis.

Clinical Spectrum and Outcome of Kidney Involvement in Non-Langerhans Histiocytosis.

Journal: Kidney international reports
Published: July 20, 2024

BRAF Deletion in Adult Patients with Langerhans Cell Histiocytosis Correlates with Multisystem Disease and Poor Outcomes.

BRAF Deletion in Adult Patients with Langerhans Cell Histiocytosis Correlates with Multisystem Disease and Poor Outcomes.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 12, 2024
Showing 1-12 of 98

Last Updated: 09/26/2026